Posts by: Diana Campelo Delgado

The Cystic Fibrosis Foundation (CFF) is awarding Eloxx Pharmaceuticals up to $2 million in additional funding to support the clinical program of ELX-02, a potential therapy for cystic fibrosis (CF) caused ... Read more

January 14, 2021January 14, 2021

Genetic Test for Advanced Breast Cancer Launched in EU

Breast Cancer News

Roche has launched a diagnostic genetic test to detect mutations in the PIK3CA gene in patients with advanced or metastatic breast cancer in the European Union. The cobas PIK3CA mutation test, performed ... Read more

January 14, 2021January 14, 2021

Include Pulmonary Sarcoidosis in Chest Pain Diagnosis, Case Report Advises

Sarcoidosis News

A case study diagnosing pulmonary sarcoidosis in a patient complaining of chest pain and shortness of breath highlights the importance of including sarcoidosis in the differential diagnosis of chest pain. ... Read more

January 13, 2021January 13, 2021

Cholesterol Metabolism Impaired in CF Mouse Model

Cystic Fibrosis News Today

The metabolism of cholesterol is impaired in a mouse model of cystic fibrosis, a preliminary study suggests. In the model, there seems to be an altered production of bile salts (those ... Read more

January 12, 2021January 12, 2021

Lemtrada May Slow MS Disease Progression, Long-term Study Suggests

Multiple Sclerosis News Today

Lemtrada (alemtuzumab) may slow the progression of multiple sclerosis (MS) and lower the conversion rate of relapsing-remitting MS (RRMS) to secondary progressive MS (SPMS), a long-term study suggests. The results showed ... Read more

January 12, 2021January 12, 2021

Orgovyx Now Available in US for Advanced Prostate Cancer

Prostate Cancer News Today

A couple of weeks after its approval, Orgovyx (relugolix) is now commercially available in the U.S. for adults with advanced prostate cancer through authorized specialty distributors, the therapy’s developer, Myovant ... Read more

January 11, 2021January 11, 2021

Targeting Calcium‐sensing Receptor May Help Slow Disease Progression

Ankylosing Spondylitis News Columns

Targeting the calcium‐sensing receptor (CaSR), which plays a critical role in the development of bone cells, may be a therapeutic strategy to slow the progression of ankylosing spondylitis (AS), a ... Read more

January 11, 2021January 12, 2021

Breast Cancer Vaccine Cleared by FDA for Human Testing

Breast Cancer News

A breast cancer vaccine can now be tested in human trials after its investigational new drug application was accepted by the U.S. Food and Drug Administration (FDA). A Phase 1 ... Read more

January 11, 2021January 11, 2021

FDA Approves Riabni, 3rd Rituxan Biosimilar to Treat GPA and MPA

ANCA Vasculitis News

The U.S. Food and Drug Administration (FDA) has approved Amgen‘s Riabni (rituximab-arrx), a biosimilar to Rituxan (rituximab), to treat adults with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), the two most common subtypes of ANCA-associated vasculitis. ... Read more

January 11, 2021January 11, 2021

Antioxidants Like Vitamin C, E May Lower Risk of Parkinson’s

Parkinson's News Today

A diet rich in antioxidants like vitamin C and E may lower a person’s risk of developing Parkinson’s disease, a large long-term study suggests. Titled “Dietary antioxidants and the risk ... Read more

January 7, 2021January 8, 2021

CXCL13, Inflammatory Marker, May Be Good at Predicting Likely MS Activity

Multiple Sclerosis News Today

CXCL13, an inflammatory biomarker, may be a good marker of likely future disease activity in people with multiple sclerosis (MS), a study suggests. The study, “Intrathecally produced CXCL13: A predictive biomarker ... Read more

January 7, 2021January 7, 2021

Dosing Begins in Phase 1 Trial of Stem Cell Therapy for Bradykinesia

Parkinson's News Today

A first patient has been dosed in IMAC Holdings’ Phase 1 clinical trial evaluating its investigational umbilical cord-derived mesenchymal stem cells (MSCs) as a potential treatment for bradykinesia, a common motor symptom ... Read more

January 7, 2021January 7, 2021

$34M Funding Helps Speed Up New Class of Cancer Diagnostics

Ovarian Cancer News Today

InterVenn Biosciences has raised $34 million to commercialize a new diagnostic tool for ovarian cancer, based on the identification of circulating proteins containing sugar molecules (glycoproteins). The company expects to ... Read more

January 7, 2021January 7, 2021

Spinogenix Wins Grant to Advance Testing of Potential Oral Therapy

ALS News Today

Spinogenix has been awarded a research grant from the U.S. Department of Defense (DOD) to further test its lead compound as a potential treatment of amyotrophic lateral sclerosis (ALS), the ... Read more

January 6, 2021January 7, 2021

3 New PHEX Gene Mutations Found in Polish Children With XLH

XLH News Today

Three new mutations in the PHEX gene — which provides instructions for making an enzyme primarily active in the bones and teeth — were found in a study of Polish ... Read more